DE60118021D1 - Medizinische aerosolzusammensetzung - Google Patents

Medizinische aerosolzusammensetzung

Info

Publication number
DE60118021D1
DE60118021D1 DE60118021T DE60118021T DE60118021D1 DE 60118021 D1 DE60118021 D1 DE 60118021D1 DE 60118021 T DE60118021 T DE 60118021T DE 60118021 T DE60118021 T DE 60118021T DE 60118021 D1 DE60118021 D1 DE 60118021D1
Authority
DE
Germany
Prior art keywords
aerosol composition
medical aerosol
medical
composition
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60118021T
Other languages
English (en)
Other versions
DE60118021T2 (de
Inventor
Philip A Jinks
Lesley Mckenzie
James T Lister
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0024711.4A external-priority patent/GB0024711D0/en
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of DE60118021D1 publication Critical patent/DE60118021D1/de
Application granted granted Critical
Publication of DE60118021T2 publication Critical patent/DE60118021T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DE60118021T 2000-10-09 2001-10-01 Medizinische aerosolzusammensetzung Expired - Lifetime DE60118021T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0024711 2000-10-09
GBGB0024711.4A GB0024711D0 (en) 2000-10-09 2000-10-09 Medicinal aerosol formulations
GB0122512 2001-09-18
GBGB0122512.7A GB0122512D0 (en) 2000-10-09 2001-09-18 Medical aerosol formations
PCT/US2001/030575 WO2002030394A2 (en) 2000-10-09 2001-10-01 Medicinal aerosol formulations

Publications (2)

Publication Number Publication Date
DE60118021D1 true DE60118021D1 (de) 2006-05-11
DE60118021T2 DE60118021T2 (de) 2006-10-26

Family

ID=26245133

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60118021T Expired - Lifetime DE60118021T2 (de) 2000-10-09 2001-10-01 Medizinische aerosolzusammensetzung

Country Status (17)

Country Link
EP (1) EP1324749B1 (de)
JP (1) JP5021149B2 (de)
CN (1) CN1635870A (de)
AR (1) AR030862A1 (de)
AT (1) ATE320242T1 (de)
AU (2) AU2002211311B2 (de)
CA (1) CA2425035A1 (de)
CZ (1) CZ2003983A3 (de)
DE (1) DE60118021T2 (de)
ES (1) ES2260299T3 (de)
HU (1) HUP0302311A3 (de)
IL (1) IL155088A0 (de)
MX (1) MXPA03002991A (de)
NO (1) NO20031597L (de)
NZ (1) NZ525054A (de)
PL (1) PL199420B1 (de)
WO (1) WO2002030394A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2474199T3 (es) 2000-11-30 2014-07-08 Vectura Limited Composiciones farmacéuticas para inhalaci�n
EP1337239B2 (de) 2000-11-30 2015-11-25 Vectura Limited Partikel zur verwendung in einer pharmazeutischen zusammensetzung
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
GB0207906D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
JP2005536538A (ja) * 2002-08-23 2005-12-02 シェーリング　コーポレイション 薬学的組成物
US7459146B2 (en) * 2003-05-30 2008-12-02 3M Innovative Properties Company Stabilized aerosol dispersions
US7109247B2 (en) * 2003-05-30 2006-09-19 3M Innovative Properties Company Stabilized particle dispersions containing nanoparticles
JP2006527237A (ja) 2003-06-13 2006-11-30 アルタナ　ファルマ　アクチエンゲゼルシャフト ホルモテロールと及びシクレソニドの組合せ物
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
GB0323684D0 (en) 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
WO2006040598A2 (en) * 2004-10-12 2006-04-20 Generics (Uk) Limited Process for the preparation of suspension aerosol formulations, wherein the particles are formed by precipitation inside an aerosol canister
EP1949891A1 (de) * 2004-10-12 2008-07-30 Generics (UK) Limited Verfahren zur Herstellung von Suspensionsaerosolformulierungen, wobei die Partikel durch Fällung im Innenkanister gebildet werden
JP5156397B2 (ja) 2005-02-10 2013-03-06 グラクソ グループ リミテッド 予備分級技術を用いて乳糖を製造する方法及びその乳糖から形成させた医薬製剤
CN100335038C (zh) * 2005-07-25 2007-09-05 江桥 含有生物活性物质和中药成分包封的无机盐纳米粒子的制备方法
CN100435784C (zh) * 2005-07-25 2008-11-26 管晓虹 含有和包封中药成分的无机盐纳米粒子的制备方法
DE102006040535A1 (de) * 2006-08-30 2008-03-13 Beiersdorf Ag Aerosolzubereitung umfassend Peloide
CN101380309B (zh) * 2007-09-03 2012-05-09 李浩莹 一种定量吸入气雾剂及其制备方法
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
GB0918150D0 (en) * 2009-10-16 2009-12-02 Jagotec Ag Improved formulations
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
WO2012171903A1 (en) 2011-06-15 2012-12-20 Nycomed Gmbh Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c]isoquinoline compounds
JP5980318B2 (ja) 2011-06-17 2016-08-31 タケダ ゲー・エム・ベー・ハーＴａｋｅｄａ ＧｍｂＨ 新規のフタラジノン−ピロロピリミジンカルボキサミド誘導体
WO2018069210A1 (en) 2016-10-10 2018-04-19 Takeda Gmbh Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4
CN109464429B (zh) * 2018-12-13 2021-04-27 上海方予健康医药科技有限公司 一种吸入压力定量气雾剂药物组合物及其制备方法
CN110755414A (zh) * 2019-11-12 2020-02-07 南京华盖制药有限公司 一种酒石酸阿福特罗气雾剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9001635D0 (en) * 1990-01-24 1990-03-21 Ganderton David Aerosol carriers
CA2213638C (en) * 1995-02-24 2004-05-04 Nanosystems L.L.C. Aerosols containing nanoparticle dispersions
US5747001A (en) * 1995-02-24 1998-05-05 Nanosystems, L.L.C. Aerosols containing beclomethazone nanoparticle dispersions

Also Published As

Publication number Publication date
WO2002030394A3 (en) 2003-01-30
PL199420B1 (pl) 2008-09-30
NO20031597D0 (no) 2003-04-08
HUP0302311A3 (en) 2006-07-28
AU2002211311B2 (en) 2006-08-31
EP1324749A2 (de) 2003-07-09
DE60118021T2 (de) 2006-10-26
EP1324749B1 (de) 2006-03-15
IL155088A0 (en) 2003-10-31
HUP0302311A2 (hu) 2003-10-28
NO20031597L (no) 2003-05-30
AU1131102A (en) 2002-04-22
ATE320242T1 (de) 2006-04-15
JP5021149B2 (ja) 2012-09-05
AR030862A1 (es) 2003-09-03
CN1635870A (zh) 2005-07-06
WO2002030394A2 (en) 2002-04-18
PL361135A1 (en) 2004-09-20
ES2260299T3 (es) 2006-11-01
MXPA03002991A (es) 2004-05-05
JP2004510808A (ja) 2004-04-08
CZ2003983A3 (cs) 2003-09-17
CA2425035A1 (en) 2002-04-18
NZ525054A (en) 2004-11-26

Similar Documents

Publication Publication Date Title
DE60118021D1 (de) Medizinische aerosolzusammensetzung
DK1524266T3 (da) Farmaceutisk sammensætning
NO20025450L (no) Ny farmasöytisk sammensetning
FI20105657A (fi) Farmaseuttisia koostumuksia
IS2932B (is) Fúlvestrant samsetning
AR028204A1 (es) Composiciones farmaceuticas electrohiladas
NO20026175L (no) Vaksinesammensetning
ATE303787T1 (de) Schergelzusammensetzungen
ITMI20010748A0 (it) Composizioni farmaceutiche
DK1317177T3 (da) Desinficerende formuleringer
DK1199054T3 (da) Væskefrakturhånddel
DE60106275T8 (de) Dermatologische zusammensetzung
PT1328154E (pt) Composicao pesticida
DE50104789D1 (de) Desodorierende Zubereitungen
AR028197A1 (es) Composiciones antitranspirantes
EE05020B1 (et) Glburiidi ravimkoostis
ATE369830T1 (de) Schweisshemmende zusammensetzungen
NO20026123L (no) Farmasöytiske sammensetninger
ATE314049T1 (de) Schweisshemmende zusammensetzungen
DE60035436D1 (de) Aerosolzusammensetzung
DE60116858D1 (de) Zusammensetzung
NO20031095L (no) Farmasoytiske sammensetninger
DE60104016D1 (de) Pestizide zusammensetzung
ATE268116T1 (de) Mesotrion-formulierungen
DE60107312D1 (de) Feste Zusammensetzung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition